Patients with psoriasis and PsA have an increased risk for cardiovascular disease. A systematic review from 2013 found surrogate markers of subclinical atherosclerosis, arterial stiffness, and cardiovascular risk factors, such as hypertension, dyslipidemia, obesity, and metabolic-related factors, were more pronounced in patients with PsA than in controls. Both cardiovascular morbidity and mortality appear to be increased in this population, equivalent to that seen in rheumatoid arthritis.
Although additional study is needed, early data suggest that suppression of inflammation with PsA treatment may decrease cardiovascular mortality.
Learn more about treatment and prognosis of PsA.
Editor's Recommendations
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Herbert S. Diamond, Eric M. Ruderman. Fast Five Quiz: Conditions Associated With Psoriatic Arthritis - Medscape - Dec 22, 2021.
Comments